These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19086374)

  • 1. Validation of a von Willebrand factor antigen enzyme-linked immunosorbent assay and newly developed collagen-binding assay.
    Burgess H; Wood D
    Can J Vet Res; 2008 Oct; 72(5):420-7. PubMed ID: 19086374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a collagen-binding activity assay as a screening test for type II von Willebrand disease in dogs.
    Sabino EP; Erb HN; Catalfamo JL
    Am J Vet Res; 2006 Feb; 67(2):242-9. PubMed ID: 16454628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of laboratory methods to improve characterization of dogs with von Willebrand disease.
    Burgess HJ; Woods JP; Abrams-Ogg AC; Wood RD
    Can J Vet Res; 2009 Oct; 73(4):252-9. PubMed ID: 20046626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of an automated chemiluminescent assay to a manual ELISA assay for determination of von Willebrand Factor collagen binding activity on VWD plasma patients previously diagnosed through molecular analysis of VWF.
    Jousselme E; Jourdy Y; Rugeri L; Négrier C; Nougier C
    Int J Lab Hematol; 2018 Feb; 40(1):77-83. PubMed ID: 28980759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative evaluation of a new fully automated assay for von Willebrand factor collagen binding activity to an established method.
    Stufano F; Baronciani L; Mane-Padros D; Cozzi G; Faraudo S; Peyvandi F
    Haemophilia; 2018 Jan; 24(1):156-161. PubMed ID: 29168270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance and clinical utility of a commercial von Willebrand factor collagen binding assay for laboratory diagnosis of von Willebrand disease.
    Popov J; Zhukov O; Ruden S; Zeschmann T; Sferruzza A; Sahud M
    Clin Chem; 2006 Oct; 52(10):1965-7. PubMed ID: 16887898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory Testing for von Willebrand Factor Collagen Binding (VWF:CB).
    Favaloro EJ; Mohammed S
    Methods Mol Biol; 2017; 1646():417-433. PubMed ID: 28804845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of commercial von Willebrand factor collagen binding assays to assist the discrimination of types 1 and 2 von Willebrand disease.
    Favaloro EJ
    Thromb Haemost; 2010 Nov; 104(5):1009-21. PubMed ID: 20806123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desmopressin therapy to assist the functional identification and characterisation of von Willebrand disease: differential utility from combining two (VWF:CB and VWF:RCo) von Willebrand factor activity assays?
    Favaloro EJ; Thom J; Patterson D; Just S; Dixon T; Koutts J; Baccala M; Rowell J; Baker R
    Thromb Res; 2009 Apr; 123(6):862-8. PubMed ID: 19064279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Application of collagen-binding assay for von Willebrand disease].
    Zhou J; Jia YQ; Jiang H; Yang YM; Deng CQ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jan; 35(1):126-9. PubMed ID: 14981837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a fully automated von Willebrand factor assay panel for the diagnosis of von Willebrand disease.
    Stufano F; Baronciani L; Bucciarelli P; Boscarino M; Colpani P; Pagliari MT; Peyvandi F
    Haemophilia; 2020 Mar; 26(2):298-305. PubMed ID: 32107842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma von Willebrand factor antigen concentration as a predictor of von Willebrand's disease status in German Wirehaired Pointers.
    Brooks M; Raymond S; Catalfamo J
    J Am Vet Med Assoc; 1996 Sep; 209(5):930-3. PubMed ID: 8790543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a von Willebrand factor three test panel and chemiluminescent-based assay system for identification of, and therapy monitoring in, von Willebrand disease.
    Favaloro EJ; Mohammed S
    Thromb Res; 2016 May; 141():202-11. PubMed ID: 26743192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential sensitivity of von Willebrand factor (VWF) 'activity' assays to large and small VWF molecular weight forms: a cross-laboratory study comparing ristocetin cofactor, collagen-binding and mAb-based assays.
    Favaloro EJ; Bonar R; Chapman K; Meiring M; Funk Adcock D
    J Thromb Haemost; 2012 Jun; 10(6):1043-54. PubMed ID: 22487084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An enzyme-linked immunosorbent assay (ELISA) for von Willebrand factor antigen (vWf-Ag) in canine plasma.
    Slappendel RJ; Frielink RA; Mol JA; Noordzij A; Hamer R
    Vet Immunol Immunopathol; 1992 Jun; 33(1-2):145-54. PubMed ID: 1632075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis or Exclusion of von Willebrand Disease Using Laboratory Testing.
    Favaloro EJ
    Methods Mol Biol; 2017; 1646():391-402. PubMed ID: 28804843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Reliable von Willebrand factor: ristocetin cofactor enzyme-linked immunosorbent assay to differentiate between type 1 and type 2 von Willebrand disease.
    Vanhoorelbeke K; Cauwenberghs N; Vandecasteele G; Vauterin S; Deckmyn H
    Semin Thromb Hemost; 2002 Apr; 28(2):161-6. PubMed ID: 11992239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study on collagen-binding enzyme-linked immunosorbent assay and ristocetin cofactor activity assays for detection of functional activity of von Willebrand factor.
    Turecek PL; Siekmann J; Schwarz HP
    Semin Thromb Hemost; 2002 Apr; 28(2):149-60. PubMed ID: 11992238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of type I, type III and type VI collagen binding assays in diagnosis of von Willebrand disease.
    Flood VH; Gill JC; Christopherson PA; Wren JS; Friedman KD; Haberichter SL; Hoffmann RG; Montgomery RR
    J Thromb Haemost; 2012 Jul; 10(7):1425-32. PubMed ID: 22507643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of a new panel of automated chemiluminescence assays for von Willebrand factor antigen and activity in the screening for von Willebrand disease.
    Verfaillie CJ; De Witte E; Devreese KM
    Int J Lab Hematol; 2013 Oct; 35(5):555-65. PubMed ID: 23551532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.